+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; Application; End User; and Geography

  • ID: 5129073
  • Report
  • June 2020
  • Region: Global
  • 184 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • Amgen, Inc.
  • BD
  • Cequr SA
  • Debiotech S.A
  • Insulet Corporation
  • Medtronic
The wearable injectors market was valued at US$ 5, 791.23 million in 2019 and is projected to reach US$ 13, 880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020-2027.

Wearable injectors are drug delivery devices adhering to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. The devices consist of a reservoir for medicine, a cannula for substance delivery to tissues, and a drive system to deliver the appropriate drug volume; it is loaded with adhesive to fix the device to the patients’ skin. The growth of the wearable injector market is attributed to the increasing chronic disease prevalence, technological advancements and design development, and conventional drug delivery system limitations, among others. However, the lack of adoption in emerging countries limits the market growth. Further, the increasing demand for biologics is a significant opportunity for the global wearable injectors market players.

Lucrative Regional Wearable Injectors Markets

market Insights

Technological Advancements and Design Development

Wearable injectors are rapidly gaining their prominence in the market owing to their capabilities in delivering a high volume of viscous formulations. The administration of pharmaceuticals via intravenous (IV) infusion is expensive in healthcare settings. Self-administration of subcutaneous injections is expected to save 30-70% of costs. Moreover, administration through conventional methods poses risks such as inaccurate dosage and needle stick injuries. The rise in the number of biologic drugs that are not suitable for oral administration has increased the adoption of wearable injection devices. Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods such as wearable injectors. For instance, the enFuse wearable injector manufactured by Enable Injections is used for subcutaneous delivery of high-volume therapeutics outside a healthcare facility. The company has also introduced mobile monitoring and more significant volume capabilities to its high-volume wearable injectors.

A new category of wearable products has emerged, bridging the gap between functionality and cost while improving patient safety and quality of life. One such example is Stevanato Group’s cartridge-based wearable device, currently under development, received Best Innovation in Drug Delivery Device award at Pharmapack Awards in 2019. The product includes a disposable, wearable pod, and reusable handheld controller that serves as the user interface and control unit for the pod. This is used for varied therapeutic areas, including diabetes, hormone therapies, pain management, and Alzheimer’s disease treatment. Moreover, continuous development by leading players in upgrading the existing wearable injector portfolio is further driving the demand for wearable injectors. For instance, in February 2020, BD, a leading global medical technology company, completed a human clinical trial of the BD Libertas Wearable Injector. The award-winning injector is currently in development and is designed as a subcutaneous drug delivery system to deliver biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations.

Products Insights

Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors. In 2019, the on-body injectors segment accounted for a larger share of the global wearable injectors market. On-body injectors ensure comfort and ease of use, confer water resistance and flexible dosing features, and facilitate automatic warming of refrigerated drugs. These benefits have led to the rise in demand for on-body injectors. Moreover, the market for off-body injectors is expected to grow at a faster pace during the forecast period, and the projected growth is attributed to the fact that these devices are free of the risks of skin fitting issues and allergic skin reactions.

End User Insights

Based on end user, the wearable injectors market is segmented into hospitals and clinics, homecare setting, and other end users. The homecare setting segment held the largest share in the global wearable injectors market in 2019. Growth of the market for this segment is attributed to expose to global trends, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system limitations. For instance, the home care segment is anticipated to dominate the market due to the growing inclination toward self-administration of medicine and the rising preference of low-cost healthcare procedures. Also, the increasing demand for technologically developed drug delivery options to lowers the frequency of hospital visits and requires minimal expertise. Moreover, the ease of use, and ready availability and accessibility has also increased the adoption of wearable injectors among patients. Hence, this has increased the use of drug delivery systems in in home care settings.

Strategic Insights

Collaborations and technology partnerships by the players operating in the market to bridge the demand-supply gap are anticipated to play a significant role in the growth of the wearable injectors market during the forecast period. Moreover, the growing number of accidents and trauma cases, and rising incidence of infectious diseases are predicted to accelerate market growth.

By Type
  • On-body Injectors
  • Off-body Injectors

By Application
  • Diabetes
  • Oncology
  • Cardiovascular Disease
  • Autoimmune Disease
  • Other Applications

By End User
  • Hospitals and Clinics
  • Homecare Setting
  • Other End User

By Geography

North America
  • US
  • Canada
  • Mexico

Europe
  • France
  • Germany
  • Italy
  • UK
  • Russia
  • Rest of Europe

Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa

South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South America

Company Profiles
  • Amgen, Inc.
  • Medtronic
  • BD
  • Insulet Corporation
  • Gerresheimer AG (Sensile Medical)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG,
  • Tandem Diabetes Care, Inc.
  • Cequr SA
  • Debiotech S.A
  • E3D Elcam Drug Delivery Devices
  • Zealand Pharma A/S (Valeritas, Inc.)

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global wearable injectors market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global wearable injectors market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen, Inc.
  • BD
  • Cequr SA
  • Debiotech S.A
  • Insulet Corporation
  • Medtronic

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Wearable Injectors Market - By Type
1.3.2 Global Wearable Injectors Market - By Application
1.3.3 Global Wearable Injectors Market - By End User
1.3.4 Global Wearable Injectors Market - By Geography
2. Wearable Injectors Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Wearable Injectors Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Wearable Injectors Market - Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Chronic Diseases Prevalence
5.1.2 Technological Advancements and Design Development
5.1.3 Conventional Drug Delivery System Limitations
5.2 Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Increasing Demand for Biologics
5.4 Future Trends
5.4.1 Integration of Wearable Injectors During Early Drug Development
5.5 Impact Analysis
6. Wearable Injectors Market - Global Analysis
6.1 Global Wearable Injectors Market Revenue Forecast and Analysis
6.2 Global Wearable Injectors Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Wearable Injectors Market- By Type
7.1 Overview
7.2 Wearable Injectors Market Share, by Type, 2019 and 2027 (%)
7.4 On-body Injectors
7.4.1 Overview
7.4.2 On-body Injectors: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
7.5 Off-body Injectors
7.5.1 Overview
7.5.2 Off-body Injectors: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
8. Wearable Injectors Market- By Application
8.1 Overview
8.2 Wearable Injectors Market Share, by Application, 2019 and 2027 (%)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
8.5 Diabetes
8.5.1 Overview
8.5.2 Diabetes: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
8.6 Autoimmune Disease
8.6.1 Overview
8.6.2 Autoimmune Disease: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
8.7 Cardiovascular Disease
8.7.1 Overview
8.7.2 Cardiovascular Disease: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
9. Wearable Injectors Market- By End User
9.1 Overview
9.2 Wearable Injectors Market Share, by End user, 2019 and 2027 (%)
9.4 Homecare Setting
9.4.1 Overview
9.4.2 Homecare Setting: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
9.5 Hospitals and Clinics
9.5.1 Overview
9.5.2 Hospitals and Clinics: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
9.6 Other End Users
9.6.1 Overview
9.6.2 Other End Users: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
10. Wearable Injectors Market - Geographic Analysis
10.1 North America: Wearable Injectors Market
10.1.1 Overview
10.1.2 North America: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.1.5 North America Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
10.1.7 US: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.1.7.4 US Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.1.8.4 Canada Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.1.9.4 Mexico Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Wearable Injectors Market
10.2.1 Overview
10.2.2 Europe: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.2.5 Europe Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.2.7.4 Germany Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UK Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.2.8.4 UK Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.2.9.4 France Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.2.10.4 Spain Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.2.11.4 Italy Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Wearable Injectors Market
10.3.1 Overview
10.3.2 Asia Pacific: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.5 Asia Pacific Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)
10.3.7 China: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.7.4 China Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.8.4 Japan Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.9.4 India Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.10.4 South Korea Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.11.4 Australia Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Wearable Injectors Market
10.4.1 Overview
10.4.2 Middle East & Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Wearable Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Wearable Injectors Market, by Country, 2018 & 2027 (%)
10.4.7 UAE: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 UAE: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 UAE Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.7.3 UAE Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.4.7.4 UAE Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.4.8 Saudi Arabia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 Saudi Arabia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 Saudi Arabia Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.8.3 Saudi Arabia Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.4.8.4 Saudi Arabia Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.4.9.4 South Africa Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Wearable Injectors Market
10.5.1 Overview
10.5.2 South and Central America: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Wearable Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.5.7.4 Brazil Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.5.8.4 Argentina Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Global Wearable Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Wearable Injectors Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 BD
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 CeQur SA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Debiotech S.A.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 E3D Elcam Drug Delivery Devices
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Insulet Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Gerresheimer AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Tandem Diabetes Care Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Zealand Pharma A/S
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 West Pharmaceutical Services, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Ypsomed AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Medtronic
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Amgen, Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Amgen, Inc.
  • Medtronic
  • BD
  • Insulet Corporation
  • Gerresheimer AG (Sensile Medical)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG,
  • Tandem Diabetes Care, Inc.
  • Cequr SA
  • Debiotech S.A
  • E3D Elcam Drug Delivery Devices
  • Zealand Pharma A/S (Valeritas, Inc.)
Note: Product cover images may vary from those shown